Translational Stroke Research From Target Selection to Clinical Trials /
Translational Stroke Research: From Target Selection to Clinical Trials is part of “Springer Series in Translational Stroke Research.” Forty-three chapters from leading stroke research groups around the world select future targets and methods for stroke management such as the vasculature and white m...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2012.
|
| Σειρά: | Springer Series in Translational Stroke Research
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Vascular Targets For Ischemic Stroke Treatment
- Identifying Vascular Targets to Treat Hemorrhagic Stroke
- Experimental Platforms For Assessing White Matter Pathophysiology In Stroke
- Neuroprotection in Stroke
- Protein Aggregation And Multiple Organelle Damage After Brain Ischemia
- Antioxidants And Stroke. Success And Pitfalls
- Caspase-Independent Stroke Targets
- Hypoxia-Inducible Factor: A New Hope To Counteract Stroke
- Thrombin in Ischemic Stroke Targeting
- Toll-Like Receptor Agonists As Antecedent Therapy For Ischemic Brain Injury: Advancing Preclinical Studies To The Nonhuman Primate
- Angiogenesis and Arteriogenesis As Stroke Targets
- Hematopoietic Growth Factor Family For Stroke Drug Development
- Soluble Epoxide Hydrolase As A Stroke Target
- Membrane Potential As Stroke Target
- Hypothermia To Identify Therapeutic Targets For Stroke Treatment
- Stroke Preconditioning To Identify Endogenous Protective Or Regenerative Mechanisms
- MicroRNAs in Ischemic Brain: The Fine-tuning Specialists and Novel Therapeutic Targets
- Neuroglobin: A Novel Target For Endogenous Neuroprotection
- Characterization Of Novel Neuroprotective Lipid Analogues For The Treatment Of Stroke
- Na+/H+ Exchangers As Therapeutic Targets For Cerebral Ischemia
- Iron as a therapeutic target in intracerebral hemorrhage: Preclinical testing of deferoxamine
- Overcoming Barriers To Translation From Experimental Stroke Models. Animal Models Of Stroke For Preclinical Drug Development: A Comparative Study Of Flavonols For Cytoprotection
- Clinical Relevance In A Translational Rodent Model Of Acute Ischemic Stroke: Incorporating The Biological Variability Of Spontaneous Recanalization
- A Clinically Relevant Rabbit Embolic Stroke Model For Acute Ischemic Stroke Therapy Development: Mechanisms & Targets
- Animal Models of Intracranial Aneurysm for treatment
- Animal Models of SAH and Their Translation to Clinical SAH
- ADME (Absorption, Distribution, Metabolism, Excretion) - The Real Meaning - Avoiding Disaster and Maintaining Efficacy for Preclinical Candidates
- CeeTox Analysis to De-risk Drug Development: The Three Antioxidants (NXY-059, RADICUT and STAZN)
- Site-Specific, Sustained-Release Drug Delivery for Subarachnoid Hemorrhage
- Therapeutic Potential of Intranasal Delivery of Drugs and Cells for Stroke and other Neurological Diseases
- High-Dose Albumin For Neuroprotection In Acute Ischemic Stroke: From Basic Investigations To Multicenter Clinical Trial
- The Translation Procedure Of Low-Level Laser Therapy In Acute Ischemic Stroke- A Non-Pharmaceutics Noninvasive Method
- Use Of Microbubbles In Acute Stroke
- Combination of High-Intensity Focused Ultrasound and Microbubbles for Stroke Treatment
- Cellular Therapy for Ischemic Stroke
- Clinical Trial Design and Repair-Based Therapies after Stroke
- A Critical Review of Stroke Trial Analytical Methodology: Outcome Measures, Study Design and Correction for Imbalances
- Metabolic Imaging in Translational Stroke Research
- Computational Analysis: A bridge to translational stroke treatment
- Innovations in stroke clinical trial design.
